Clean range

Expert in desloughing

  • Pain-free and atraumatic dressing changes
  • Wide range of dressings

picto_prepare_nb picto_clean picto_accelerate_nb picto_close_nb

 

 

 

 

Discover UrgoClean range!

Principle

The procedure of desloughing a wound, can be difficult for clinicians (removing slough without pain and avoiding bleeding) but also unpleasant and painful for patients (manual debridement, bleeding…). For this reason, Urgo Medical has developed UrgoClean, an innovative solution, which prepares sloughy and exuding wounds effectively and efficiently to improve healing. 

 

Mode of action

When in contact with exudate, the poly-absorbent fibres  gel, swell and bind to the sloughy residue within the wound, absorbing and draining it to aid elimination. The creation of this gel in contact with the wound, maintains a moist environment, which promotes the healing of desloughed areas and traps exudate preventing any lateral diffusion.

 

Mode of action

 

Indications

Exuding and sloughy wounds (leg ulcers, pressure ulcers, diabetic foot ulcers, burns, skin abrasions, traumatic wounds, postoperative wounds…)

clean01

 

Contra-indications

-        Do not use if there is a known sensitivity to UrgoClean.

-        Do not use Urgoclean as a surgical sponge for heavily bleeding wounds

 

Key benefits

  • Absorbs exudate, traps and retains slough and bacteria
  • Is removed in one piece
  • Provides atraumatic and painfree dressing changes

 

Range

range_clean03

 

Clinical Evidence

UrgoReviewTC23Feb_Web earth-study-march-2014  
Supporting evidence-based practice: a clinical review of TLC technology Evaluation of two fibrous wound dressings for the management of leg ulcers: Results of a European randomised controlled trial (EARTH RCT)  
Download Download  

 

Management of chronic wounds with an innovative absorbent wound dressing

Meaume S. et al, journal of wound care vol 21 , no 7 , July 2012

  • Objective: To evaluate the efficacy and tolerability of an innovative absorbent wound dressing (UrgoClean; Laboratoires Urgo) in the local management of venous leg ulcers and pressure ulcers, during the sloughy stage of the healing process.
  • Method: A pilot, prospective, non-controlled open-label clinical trial held in 21 investigating centres. Adult patients, presenting with either a venous leg ulcer (VLU ) or a category III /IV pressure ulcer (PU ) with more than 50% of the surface area covered with sloughy tissue, a duration of less than 24 months, and no clinical signs of infection were included in the study. Patients were followed over a 6-week period with weekly visits, which included a physical examination, wound-area tracings and photographs by the investigating physician. Evaluations by the nursing staff and by the patients were made at each dressing change.
  • Results: Fifty patients with either a VLU (n=35) or a PU (n=15) were recruited. At baseline, mean wound surface area was 11.9 ± 11.3 cm2 and 12.5 ± 10.7 cm2, with a mean duration of 8.3 ± 6.4 months and 2.9 ± 3.0 months in the VLU and PU groups, respectively. Wounds in both groups were covered with more than 70% sloughy tissue, and the peri-lesional skin was considered to be healthy in 19 patients. By 6 weeks, mean wound surface area reduction in the VLU and PU groups was 23.7% and 29.2%, respectively, with full healing in 6 patients. All treated wounds were considered to be debrided by week 3 (< 40% slough for all wounds) and the median relative decrease of the sloughy tissue, at week 6, in the VLU and PU groups was 75% and 89%, respectively. Dressing acceptability was documented as being very good for both patients and nursing staff, particularly conformability and ease of use, with no residue left on the wound bed at dressing removal and the dressing also remained in one piece. Seven local adverse events were deemed to be potentially related to the trial dressing.
  • Conclusion: The results suggest that the dressing promoted the healing process of chronic wounds, showing itself to be a credible therapeutic alternative for the sloughy stage of the wound-healing process. It also demonstrated good tolerance and acceptability.
Last update : December 9, 2017